Professor Ivo Mueller is a malaria epidemiologist, jointly appointed as Co-Division Head of the Population Health and Immunity Division at The Walter and Eliza Hall Institute in Melbourne and Head of the Malaria Parasites and Hosts laboratory in the Department of Parasites and Insect Vectors at The Institut Pasteur in Paris.Related Projects
- Developing better tools for diagnosing patients and populations at risk of primaquine induced haemolysis
- Developing serological markers of recent exposure to malaria
- Epidemiological modelling for malaria elimination
- Identifying “hot spots” and “hot pops” with serological surveillance and operational research of high sensitivity tests
- Identifying populations at risk of multidrug resistant malaria
- Impact of declining transmission on malaria treatment outcomes, immunity and risk of rebound
- Molecular surveillance of malaria parasites to inform on local intervention strategies
- Relatedness of successive Plasmodium vivax infections
- Using pharmacogenomics to improve anti-malarial treatment
Related Publications
- A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria
- Acquisition and longevity of antibodies to Plasmodium vivax pre-erythrocytic antigens in Western Thailand
- Acquisition of antibodies against endothelial protein C receptor-binding domains of Plasmodium falciparum erythrocyte membrane protein 1 in children with severe malaria
- Acquisition of antibodies to Plasmodium falciparum and Plasmodium vivax antigens in pregnant women living in a low malaria transmission area of Brazil
- An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
- Antibody targets on the surface of Plasmodium falciparum-infected erythrocytes that are associated with immunity to severe malaria in young children
- Asia-Pacific ICEMR: Understanding Malaria Transmission to Accelerate Malaria Elimination in the Asia Pacific Region
- Asia-Pacific International Center of Excellence in Malaria Research: Maximizing Impact on Malaria Control Policy and Public Health in Cambodia and Papua New Guinea
- Assessment of IgG3 as a serological exposure marker for Plasmodium vivax in areas with moderate-high malaria transmission intensity
- Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand
- Blood-Stage Parasitaemia and Age Determine Plasmodium falciparum and P. vivax Gametocytaemia in Papua New Guinea
- Decreasing malaria prevalence and its potential consequences for immunity in pregnant women
- Effect of out-of-village working activities on recent malaria exposure in the Peruvian Amazon using parametric g-formula
- Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children
- Genomic analysis of local variation and recent evolution in Plasmodium vivax
- Genomic epidemiology of artemisinin resistant malaria
- Global diversity and balancing selection of 23 leading Plasmodium falciparum candidate vaccine antigens
- Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children
- Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against clinical malaria
- Identification and prioritization of merozoite antigens as targets of protective human immunity to falciparum malaria for vaccine and biomarker development
- Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development
- Identification of novel Plasmodium vivax proteins associated with protection against clinical malaria
- Identity-by-descent analyses for measuring population dynamics and selection in recombining pathogens
- Increasingly inbred and fragmented populations of Plasmodium vivax associated with the eastward decline in malaria transmission across the Southwest Pacific
- Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial
- Iron deficiency during pregnancy is associated with a reduced risk of adverse birth outcomes in a malaria-endemic area in a longitudinal cohort study
- Longitudinal IgG antibody responses to Plasmodium vivax blood-stage antigens during and after acute vivax malaria in individuals living in the Brazilian Amazon
- Microscopic and submicroscopic Plasmodium falciparum infection, maternal anaemia and adverse pregnancy outcomes in Papua New Guinea: a cohort study
- Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission
- Monitoring Plasmodium falciparum and Plasmodium vivax using microsatellite markers indicates limited changes in population structure after substantial transmission decline in Papua New Guinea
- Nationwide genetic surveillance of Plasmodium vivax in Papua New Guinea reveals heterogeneous transmission dynamics and routes of migration among subdivided populations
- Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions
- Population heterogeneity in Plasmodium vivax relapse risk
- Protective Immunity against Severe Malaria in Children Is Associated with a Limited Repertoire of Antibodies to Conserved PfEMP1 Variants
- Strategies for Understanding and Reducing the Plasmodium vivax and Plasmodium ovale Hypnozoite Reservoir in Papua New Guinean Children: A Randomised Placebo-Controlled Trial and Mathematical Model
- Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial
- Sustained Malaria Control Over an 8-Year Period in Papua New Guinea: The Challenge of Low-Density Asymptomatic Plasmodium Infections
- Targets of complement-fixing antibodies in protective immunity against malaria in children
- The efficacy of dihydroartemisininpiperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis
- The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network
- The spatial signature of Plasmodium vivax and Plasmodium falciparum infections: quantifying the clustering of infections in cross-sectional surveys and cohort studies
- Ultra-Sensitive Detection of Plasmodium falciparumby Amplification of Multi-Copy Subtelomeric Targets